Table 4.
Characteristics of 221 cardiac Individual Case Safety Reports.
| Cardiac Individual Case Safety Reports 221 (%) |
|
|---|---|
| Gender | |
| Female | 89 (40.3) |
| Male | 132 (59.7) |
| Age group | |
| 12–17 Years | 1 (0.5) |
| 18–64 Years | 83 (37.6) |
| 2 Months–2 Years | 1 (0.5) |
| 65–85 Years | 87 (39.4) |
| More Than 85 Years | 31 (14.0) |
| Not Specified | 18 (8.1) |
| Outcome | |
| Fatal | 69 (31.2) |
| Not Recovered/Not Resolved | 35 (15.8) |
| Recovered/Resolved | 60 (27.1) |
| Recovered/Resolved With Sequelae | 3 (1.4) |
| Recovering/Resolving | 9 (4.1) |
| Unknown | 45 (20.4) |
| N. of cardiac events per ICSR | |
| 1 | 178 (80.5) |
| 2 | 28 (12.7) |
| 3 | 9 (4.1) |
| 4 | 3 (1.4) |
| 5 | 3 (1.4) |
| Overall Adverse Events | |
| Total number | 841 |
| Median per ICSR | 2 (1–17) |
| Other drugs | |
| Total number | 2372 |
| Median per ICSR | 8 (0–52) |
| Other drugs for cardiovascular diseases | |
| Yes | 166 (75.1) |
| No | 55 (24.9) |
| Other cardiotoxic drugs (azithromycin or hydroxychloroquine) | |
| Yes | 56 (25.3) |
| No | 165 (74.7) |